Search details
1.
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CML.
Cancer Sci
; 114(3): 995-1006, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36336963
2.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37232264
3.
Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor.
Cancer Sci
; 111(10): 3714-3725, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-33404088
4.
R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.
Cancer Sci
; 109(9): 2830-2840, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29957865
5.
Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.
Ann Hematol
; 97(1): 73-81, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29196987
6.
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.
Am J Hematol
; 92(4): 367-374, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28103625
7.
Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.
Biochim Biophys Acta
; 1839(4): 265-74, 2014.
Article
in English
| MEDLINE | ID: mdl-24530422
8.
Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach.
Anal Bioanal Chem
; 407(18): 5273-80, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25957845
9.
Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
Ann Hematol
; 93(6): 957-63, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24441947
10.
Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosis.
Rinsho Ketsueki
; 55(5): 558-62, 2014 05.
Article
in Japanese
| MEDLINE | ID: mdl-24881922
11.
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97.
Cancer Sci
; 104(10): 1339-45, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23837667
12.
JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
Mol Carcinog
; 52(1): 57-69, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-22086844
13.
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study.
Blood
; 117(8): 2358-65, 2011 Feb 24.
Article
in English
| MEDLINE | ID: mdl-20693429
14.
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.
Blood
; 117(8): 2366-72, 2011 Feb 24.
Article
in English
| MEDLINE | ID: mdl-21190996
15.
Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression.
Int J Cancer
; 130(5): 1046-59, 2012 Mar 01.
Article
in English
| MEDLINE | ID: mdl-21400515
16.
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study.
Cancer Sci
; 103(6): 1071-8, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22364419
17.
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in Japan.
Cancer Sci
; 103(10): 1839-47, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22816487
18.
Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients.
Eur J Clin Pharmacol
; 68(10): 1411-8, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22441315
19.
Detection of fluoroquinolone-induced tendon disorders using a hospital database in Japan.
Pharmacoepidemiol Drug Saf
; 21(8): 886-9, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22532516
20.
Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2.
Nagoya J Med Sci
; 74(3-4): 261-71, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-23092099